Effect of Sex and Age Interactions on Functional Outcome after Stroke

被引:51
作者
Kim, Tae-Hee [1 ,2 ]
Vemuganti, Raghu [1 ,2 ]
机构
[1] Univ Wisconsin, Dept Neurol Surg, Sch Med & Publ Hlth, Madison, WI 53792 USA
[2] Univ Wisconsin, Neurosci Training Program, Sch Med & Publ Hlth, Madison, WI 53792 USA
关键词
Aging; Cerebral ischemia; Hormones; microRNAs; Neuroprotection; Sex differences; Thrombolytic agents; CEREBRAL-ARTERY OCCLUSION; TRANSIENT FOCAL ISCHEMIA; RECEPTOR MODULATORS DECREASE; BLOOD-BRAIN-BARRIER; PLASMINOGEN-ACTIVATOR; 17-BETA-ESTRADIOL PROTECTS; INFLAMMATORY RESPONSE; ATRIAL-FIBRILLATION; GLUTAMATE RELEASE; HYPOXIA-ISCHEMIA;
D O I
10.1111/cns.12346
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Stroke is one of the leading causes of death and disability worldwide. Experimental and clinical studies showed that sex and age play an important role in deciding the outcome after stroke. At younger ages, males were shown to have a higher risk for stroke than females. However, this trend reverses in older ages particularly when females reach menopause. Many preclinical studies indicate that steroid hormones modulate the age-dependent differential stroke outcome. In addition, patterns of cell death pathways activated following cerebral ischemia are distinct between males and females, but independent of steroid hormones. Recent studies also indicate that microRNAs play important roles in mediating sex-specific stroke outcome by regulating stroke-related genes. This review discusses the contribution of sex and age to outcome after stroke with particular emphasis on the experimental studies that examined the effects of steroid hormones, differential cell death pathways, and involvement of sex-specific microRNAs following cerebral ischemia. Current understanding of the role of thrombolytic agents in stroke therapy is also discussed.
引用
收藏
页码:327 / 336
页数:10
相关论文
共 148 条
[81]  
Lyden P, 2013, CURR PHARM DESIGN, V19, P7479
[82]   Thrombolysis in stroke:: Inappropriate consideration of the 'window period' as the time available [J].
Maestre-Moreno, JF ;
Fernández-Pérez, MD ;
Arnáiz-Urrutia, C ;
Mínguez, A ;
Navarrete-Navarro, P ;
Martínez-Bosch, J .
REVISTA DE NEUROLOGIA, 2005, 40 (05) :274-278
[83]   Neuroscience - Energy on demand [J].
Magistretti, PJ ;
Pellerin, L ;
Rothman, DL ;
Shulman, RG .
SCIENCE, 1999, 283 (5401) :496-497
[84]  
Manwani B, 2011, WOMENS HEALTH, V7, P319, DOI [10.2217/whe.11.22, 10.2217/WHE.11.22]
[85]   Estrogen and ischemic neuroproltection: an integrated view [J].
McCullough, LD ;
Hurn, PD .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2003, 14 (05) :228-235
[86]   Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection [J].
McCullough, LD ;
Zeng, ZY ;
Blizzard, KK ;
Debchoudhury, I ;
Hurn, PD .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2005, 25 (04) :502-512
[87]   Molecular targets in cerebral ischemia for developing novel therapeutics [J].
Mehta, Suresh L. ;
Manhas, Namratta ;
Rahubir, Ram .
BRAIN RESEARCH REVIEWS, 2007, 54 (01) :34-66
[88]   Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: Therapeutic time window, combination with t-PA and efficacy in aged rats [J].
Murakami, Koji ;
Suzuki, Motohisa ;
Suzuki, Noriko ;
Hamajo, Kazuhiro ;
Tsukamoto, Tetsuya ;
Shimojo, Masato .
BRAIN RESEARCH, 2013, 1526 :84-93
[89]   G Protein-Coupled Estrogen Receptor Agonist Improves Cerebral Microvascular Function After Hypoxia/Reoxygenation Injury in Male and Female Rats [J].
Murata, Takahiro ;
Dietrich, Hans H. ;
Xiang, Chuanxi ;
Dacey, Ralph G., Jr. .
STROKE, 2013, 44 (03) :779-+
[90]  
Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1